Koca T, Gocen Vardar N, Aksoy R, Korcum A
Curr Oncol. 2025; 32(1).
PMID: 39851955
PMC: 11763994.
DOI: 10.3390/curroncol32010039.
Staniewska E, Grudzien K, Stankiewicz M, Raczek-Zwierzycka K, Rembak-Szynkiewicz J, Nowicka Z
Cancers (Basel). 2024; 16(8).
PMID: 38672624
PMC: 11049631.
DOI: 10.3390/cancers16081542.
Jin L, Cao F, Zhang Y, Dang Y, Wang F
Transl Cancer Res. 2024; 13(3):1323-1335.
PMID: 38617514
PMC: 11009798.
DOI: 10.21037/tcr-23-1501.
Avisha M, Pelupessy N, Rahman A, Rauf S, Rakhmah N, Hamid F
Turk J Obstet Gynecol. 2023; 20(4):285-292.
PMID: 38073222
PMC: 10711526.
DOI: 10.4274/tjod.galenos.2023.80912.
Tsai Y, Lai C, Chang G, Hsu C, Tsai M, Liao C
Cancers (Basel). 2023; 15(9).
PMID: 37173956
PMC: 10177202.
DOI: 10.3390/cancers15092492.
The relationship between food quality score with inflammatory biomarkers, and antioxidant capacity in young women.
Bahrami A, Nikoomanesh F, Khorasanchi Z, Mohamadian M, Ferns G
Physiol Rep. 2023; 11(2):e15590.
PMID: 36695752
PMC: 9875818.
DOI: 10.14814/phy2.15590.
Predictive value of hemogram parameters in malignant transformation of the endometrium in patients with different risk factors.
Firat A, Ercan A, Mordeniz C, Verit Atmaca F
PLoS One. 2023; 18(1):e0279224.
PMID: 36626395
PMC: 9831310.
DOI: 10.1371/journal.pone.0279224.
Systemic inflammation with sarcopenia predicts survival in patients with gastric cancer.
Liu Y, Ruan G, Ge Y, Li Q, Zhang Q, Zhang X
J Cancer Res Clin Oncol. 2022; 149(3):1249-1259.
PMID: 35435489
DOI: 10.1007/s00432-022-03925-2.
MRI Radiomic Features: A Potential Biomarker for Progression-Free Survival Prediction of Patients With Locally Advanced Cervical Cancer Undergoing Surgery.
Cai M, Yao F, Ding J, Zheng R, Huang X, Yang Y
Front Oncol. 2021; 11:749114.
PMID: 34970482
PMC: 8712932.
DOI: 10.3389/fonc.2021.749114.
Neutrophil-to-Lymphocyte Ratio (NLR) and Monocyte-to-Lymphocyte Ratio (MLR) Predict Clinical Outcome in Patients with Stage IIB Cervical Cancer.
Li Y, Chang J, He M, Wang H, Luo D, Li F
J Oncol. 2021; 2021:2939162.
PMID: 34539781
PMC: 8443385.
DOI: 10.1155/2021/2939162.
and studies of essential oil reveal the potential harmful effects of habitual consumption of the plant seed.
Daniyan M, Adeyipo T, Oyemitan I, Okwuese P, Ekundina V, Akanmu M
Toxicol Rep. 2021; 8:1488-1497.
PMID: 34401359
PMC: 8353414.
DOI: 10.1016/j.toxrep.2021.07.019.
The role of inflammation biomarkers in differential diagnosis of pelvic tumours of ovarian origin: a single-centre observational study.
Psomiadou V, Prodromidou A, Galati E, Kostakis I, Maliaros A, Mamais I
Contemp Oncol (Pozn). 2021; 25(1):7-11.
PMID: 33911975
PMC: 8063895.
DOI: 10.5114/wo.2021.105072.
Neutrophil-To-Lymphocyte and Platelet-To-Lymphocyte Ratios as Prognostic Markers of Survival in Patients with Head and Neck Tumours-Results of a Retrospective Multicentric Study.
Szilasi Z, Josa V, Zrubka Z, Mezei T, Vass T, Merkel K
Int J Environ Res Public Health. 2020; 17(5).
PMID: 32155982
PMC: 7084240.
DOI: 10.3390/ijerph17051742.
Clinical significance of PD-L1 (CD274) enhanced expression in cervical squamous cell carcinoma.
Feng M, Xu L, He Y, Sun L, Zhang Y, Wang W
Int J Clin Exp Pathol. 2020; 11(11):5370-5378.
PMID: 31949618
PMC: 6963033.
Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Discriminating Precancerous Pathologies from Cervical Cancer.
Tas M, Yavuz A, Ak M, Ozcelik B
J Oncol. 2019; 2019:2476082.
PMID: 31558903
PMC: 6735215.
DOI: 10.1155/2019/2476082.
The value of neutrophil to lymphocyte ratio and gamma-glutamyl transpeptidase to platelet ratio in patients with hepatocellular carcinoma.
Hu Z, Chen H, Chen S, Huang Z, Qin S, Zhong J
Medicine (Baltimore). 2019; 98(9):e14749.
PMID: 30817633
PMC: 6831363.
DOI: 10.1097/MD.0000000000014749.
Preoperative Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Are Not Clinically Useful in Predicting Prognosis in Early Stage Cervical Cancer.
Nuchpramool P, Hanprasertpong J
Surg Res Pract. 2019; 2018:9162921.
PMID: 30631798
PMC: 6304836.
DOI: 10.1155/2018/9162921.
Relationship of Red Blood Cell Distribution Width with Cancer Mortality in Hospital.
Li J, Yang X, Ma J, Gong F, Chen Q
Biomed Res Int. 2018; 2018:8914617.
PMID: 30539025
PMC: 6261390.
DOI: 10.1155/2018/8914617.
Pretreatment neutrophil to lymphocyte and platelet to lymphocyte ratios as predictive factors for the survival of cervical adenocarcinoma patients.
Jonska-Gmyrek J, Gmyrek L, Zolciak-Siwinska A, Kowalska M, Fuksiewicz M, Kotowicz B
Cancer Manag Res. 2018; 10:6029-6038.
PMID: 30538552
PMC: 6257078.
DOI: 10.2147/CMAR.S178745.
The pretreatment platelet-to-lymphocyte ratio predicts clinical outcomes in patients with cervical cancer: A meta-analysis.
Ma J, Ke L, Liu Q
Medicine (Baltimore). 2018; 97(43):e12897.
PMID: 30412089
PMC: 6221620.
DOI: 10.1097/MD.0000000000012897.